Antidepressants in Spine Surgery: A Systematic Review to Determine Benefits and Risks
Open Access
- 31 December 2019
- journal article
- review article
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 13 (6) , 1036-1046
Abstract
Antidepressant drugs can be advantageous in treating psychiatric and non-psychiatric illnesses, including spinal disorders. However, spine surgeons remain unfamiliar with the advantages and disadvantages of the use of antidepressant drugs as a part of the medical management of diseases of the spine. Our review article describes a systematic method using the PubMed/Medline database with a specific set of keywords to identify such benefits and drawbacks based on 17 original relevant articles published between January 2000 and February 2018; this provides the community of spine surgeons with available cumulative evidence contained within two tables illustrating both observational (10 studies; three cross-sectional, three case-control, and four cohort studies) and interventional (seven randomized clinical trials) studies. While tricyclic antidepressants (e.g., amitriptyline) and duloxetine can be effective in the treatment of neuropathic pain caused by root compression, venlafaxine may be more appropriate for patients with spinal cord injury presenting with depression and/or nociceptive pain. Despite the potential associated consequences of a prolonged hospital stay, higher cost, and controversial reports regarding the lowering of bone mineral density in the elderly, antidepressants may improve patient satisfaction and quality of life following surgery, and reduce postoperative pain and risk of delirium. The preoperative treatment of preexisting psychiatric diseases, such as anxiety and depression, can improve outcomes for patients with spinal cord injury-related disabilities; however, a preoperative platelet function assay is advocated prior to major spine surgical procedures to protect against significant intraoperative blood loss, as serotonergic antidepressants (e.g., selective serotonin reuptake inhibitors) and bupropion can increase the likelihood of bleeding intraoperatively due to drug-induced platelet dysfunction. This comprehensive review of this evolving topic can assist spine surgeons in better understanding the benefits and risks of antidepressant drugs to optimize outcomes and avoid potential hazards in a spine surgical setting.Keywords
This publication has 31 references indexed in Scilit:
- Serotonergic Antidepressants Are Associated with Increased Blood Loss and Risk for Transfusion in Single-Level Lumbar Fusion SurgeryAsian Spine Journal, 2017
- Depression as an independent predictor of postoperative delirium in spine deformity patients undergoing elective spine surgeryJournal of Neurosurgery: Spine, 2017
- Pretreatment of Depression Before Cervical Spine Surgery Improves Patients' Perception of Postoperative Health Status: A Retrospective, Single Institutional ExperienceWorld Neurosurgery, 2016
- Efficacy of Venlafaxine XR for the Treatment of Pain in Patients With Spinal Cord Injury and Major Depression: A Randomized, Controlled TrialArchives of Physical Medicine and Rehabilitation, 2015
- Pain management following spinal surgeries: An appraisal of the available optionsJournal of Craniovertebral Junction and Spine, 2015
- Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviewsBMC Family Practice, 2013
- Antidepressants and the risk of abnormal bleeding during spinal surgery: a case–control studyEuropean Spine Journal, 2012
- Psychological morbidity and spinal cord injury: a systematic reviewSpinal Cord, 2008
- Preoperative Predictors for Postoperative Clinical Outcome in Lumbar Spinal StenosisSpine, 2006
- Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trialPain, 2002